This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Natural History Study of Patients With Excess Androgen | MicrobiomeTrials

NCT00250159

Natural History Study of Patients With Excess Androgen

RecruitingOBSERVATIONAL

Trial Details

Start: 2006-01-02

Enrollment target: 3,000 participants

Locations

Medstar Washington Hospital Center, Washington D.C., District of Columbia, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Contact

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia

The purpose of this Phase 2, open-label, sequential dose cohort study is to evaluate the safety, efficacy, and pharmacok…

Pasadena, United StatesCompleted Aug 22, 2025

Congenital Adrenal Hyperplasia

The main objective of this study is to assess the safety and tolerability of crinecerfont in pediatric participants 3 mo…

San Francisco, United StatesEst. completion Mar 2028

Congenital Adrenal Hyperplasia (CAH)

The goal of this study is to explore the safety, drug concentrations and effects on adrenal gland hormones after a singl…

Multiple LocationsEst. completion May 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.